On this page
asco 2022
Explore " asco 2022" with insightful episodes like "Advances in Gynecologic Cancers from the 2022 ASCO Annual Meeting with Dr Brian Slomovitz", "Key Presentations on Genitourinary Cancers from the 2022 ASCO Annual Meeting with Dr Sandy Srinivas", "ASCO 2022: What’s New in Mantle Cell Lymphoma" and "The OJC 66: ASCO 2022 GI Special with Jeanne Tie" from podcasts like ""Oncology Today with Dr Neil Love", "Oncology Today with Dr Neil Love", "PCE" and "The Oncology Podcast"" and more!
Episodes (4)
Key Presentations on Genitourinary Cancers from the 2022 ASCO Annual Meeting with Dr Sandy Srinivas
ASCO 2022: What’s New in Mantle Cell Lymphoma
In this episode, Tycel J. Phillips, MD, and Amy Goodrich, RN, MSN, CRNP-AC, provide expert insights on key data presented at ASCO 2022 for mantle cell lymphoma regarding:
- Results from the phase III SHINE study of the addition of ibrutinib the first-line BR followed by rituximab maintenance in older patients with MCL
- Updated results from the phase II ZUMA-2 study evaluating brexucabtagene autoleucel for patients with R/R MCL
- Results from a phase I/II study of the ROR1 humanized monoclonal antibody, zilovertamab, in combination with ibrutinib for patients with R/R MCL, MZL, or CLL/SLL
- Preliminary results from a phase I study of the humanized ROR1xCD3 bispecific antibody, NVG-111, in R/R CLL and MCL after ≥2 previous therapies
Presenters:
Tycel J. Phillips, MD
Maria Reinhardt Decesare Research Professor of Blood Cancers and Bone Marrow Transplantation
Associate Professor of Medicine
University of Michigan
Rogel Cancer Center
Ann Arbor, Michigan
Amy Goodrich, RN, MSN, CRNP-AC
Research Associate, Department of Medicine
Johns Hopkins University
Nurse Practitioner, Department of Medicine
The Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland
Content supported by educational grants from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
Link to full program, including a downloadable highlights slideset:
https://bit.ly/3yufCU4
The OJC 66: ASCO 2022 GI Special with Jeanne Tie
The Oncology Journal Club - Delivering Oncology News Differently
The Oncology Podcast, brought to you by The Oncology Network, is proud to present Episode 66 in our series The Oncology Journal Club.
Today’s episode is an ASCO 2022 Special… Craig Underhill talks to Jeannie Tie about all things ctDNA. Jeanne talks us through the dynamic trial… an overnight success only 12 years in the making.
You’ll find links to all the papers, bios and Twitter handles in the notes on our websites. For regular news and podcast updates, we invite healthcare professionals to join us at oncologynetwork.com.au. It's free and it’s a fantastic way to support the OJC.
The Oncology Podcast - An Australian Oncology Perspective